SC
CELG

Samlyn Capital’s Celgene Corp CELG Stock Holding History

Samlyn Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-381,600
Closed -$36.2M – 122
2014
Q3 		$36.2M Sell
381,600
-98,400
-21% -$8.88M 0.75% 59
2014
Q2 		$41.2M Buy
480,000
+79,332
+20% +$6.03M 0.94% 49
2014
Q1 		$28M Buy
+400,668
New +$31.7M 0.65% 63

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Samlyn Capital's CELG Position: Q4 2014 in Review

Samlyn Capital sold out of Celgene Corp (CELG) in Q4 2014, closing a stake of 381,600 shares — an estimated $36.2M sold.

Samlyn Capital first reported a position in CELG in Q1 2014 and held it in 3 quarters. The position peaked at $41.2M in Q2 2014. 1,161 funds tracked by Wall St. Rank hold CELG as of Q4 2014.

  • Samlyn Capital reported no remaining Celgene Corp position as of Q4 2014 after selling out during the quarter.
  • Samlyn Capital sold 381,600 Celgene Corp shares in Q4 2014, an estimated $36.2M.
  • Samlyn Capital first reported a position in Celgene Corp in Q1 2014 and held it in 3 quarters.
  • Samlyn Capital's Celgene Corp position peaked at $41.2M in Q2 2014.
  • 1,161 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2014.

Based on Samlyn Capital's 13F filing for Q4 2014, filed 17 Feb 2015.